Cohance Lifesciences Board Meeting on Aug 5 to Approve Unaudited Financials

Cohance Lifesciences Ltd has announced that its Board of Directors will convene on August 5, 2026. The primary agenda item for this meeting is to consider and approve the company's Unaudited Financial Results for both standalone and consolidated operations for the quarter ended June 30, 2026. The trading window for designated persons will remain closed until August 7, 2026.